Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor

Jia Shi; Bo Dong; Yumin Mao; Wei Guan; Jiachao Cao; Rongxing Zhu; Suinuan Wang

doi:10.18632/oncotarget.11958

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor

Jia Shi, Bo Dong, Yumin Mao, Wei Guan, Jiachao Cao, Rongxing Zhu and Suinuan Wang _

PDF | HTML | How to cite

Oncotarget. 2016; 7:71052-71061. https://doi.org/10.18632/oncotarget.11958

Metrics: PDF 3988 views | HTML 6171 views | ?

Abstract

Jia Shi1,*, Bo Dong1,*, Yumin Mao1, Wei Guan1, Jiachao Cao1, Rongxing Zhu1 and Suinuan Wang1

1 Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, China

* These authors have contributed equally to this work

Correspondence to:

Suinuan Wang, email:

Keywords: hyperglycemia, traumatic brain injury, blood glucose, glycemic control

Received: May 27, 2016 Accepted: September 02, 2016 Published: September 10, 2016

Abstract

Hyperglycemia after severe traumatic brain injury (TBI) occurs frequently and is associated with poor clinical outcome and increased mortality. In this review, we highlight the mechanisms that lead to hyperglycemia and discuss how they may contribute to poor outcomes in patients with severe TBI. Moreover, we systematically review the proper management of hyperglycemia after TBI, covering topics such as nutritional support, glucose control, moderated hypothermia, naloxone, and mannitol treatment. However, to date, an optimal and safe glycemic target range has not been determined, and may not be safe to implement among TBI patients. Therefore, there is a mandate to explore a reasonable glycemic target range that can facilitate recovery after severe TBI.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11958

Publication Alerts

Reviews:

Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor

Abstract